HER2-Altered Non-Small Cell Lung Cancer — An Interview with Dr John V Heymach (Companion Faculty Lecture)
Research To Practice | Oncology Videos · Dr. Neil Love
December 9, 202526m 15s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring a slide presentation and related discussion from Dr John V Heymach, including the following topics:
- Overview of the biology and treatment landscape of HER2-mutant non-small cell lung cancer (NSCLC) (0:00)
- Datasets evaluating trastuzumab deruxtecan for HER2-mutant NSCLC (5:03)
- Clinical data with zongertinib for HER2-mutant NSCLC (6:35)
- Emerging data with sevabertinib for HER2-mutant NSCLC (14:41)
- Other investigational strategies being evaluated for HER2-mutant NSCLC (19:10)
- Summary of the current and future treatment landscape of HER2-mutant NSCLC (21:52)